X
53.41
-1.32 (-2.41%)
| Penutupan Terdahulu | 54.73 |
| Buka | 54.43 |
| Jumlah Dagangan | 1,263,915 |
| Purata Dagangan (3B) | 1,470,539 |
| Modal Pasaran | 5,162,907,136 |
| Harga / Jualan (P/S) | 591.55 |
| Harga / Buku (P/B) | 3.95 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -969.84% |
| EPS Cair (TTM) | -3.22 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.23% |
| Nisbah Semasa (MRQ) | 17.66 |
| Aliran Tunai Operasi (OCF TTM) | -196.85 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -128.49 M |
| Pulangan Atas Aset (ROA TTM) | -22.03% |
| Pulangan Atas Ekuiti (ROE TTM) | -31.60% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Xenon Pharmaceuticals Inc. | Menaik | Menaik |
AISkor Stockmoo
0.5
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.50 |
|
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 0.14% |
| % Dimiliki oleh Institusi | 103.51% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 97.00 (Baird, 81.61%) | Beli |
| Median | 77.00 (44.17%) | |
| Rendah | 64.00 (Wedbush, 19.83%) | Beli |
| Purata | 78.83 (47.59%) | |
| Jumlah | 6 Beli | |
| Harga Purata @ Panggilan | 61.33 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Deutsche Bank | 10 Mar 2026 | 90.00 (68.51%) | Beli | 60.61 |
| HC Wainwright & Co. | 10 Mar 2026 | 74.00 (38.55%) | Beli | 60.61 |
| Wedbush | 10 Mar 2026 | 64.00 (19.83%) | Beli | 60.61 |
| Wells Fargo | 10 Mar 2026 | 68.00 (27.32%) | Beli | 60.61 |
| Baird | 09 Mar 2026 | 97.00 (81.61%) | Beli | 62.76 |
| Needham | 09 Mar 2026 | 80.00 (49.78%) | Beli | 62.76 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |